Peregrine Ventures is a investment firm based in Or Yehuda, Israel. It has made 2 investments, with focus areas including Biotech & Life Sciences.
Portfolio
2
Fund Size
$600M
Top Stage
Series B
Last 12 Mo
0
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Lutris Pharma | Series B | $30M | Jan 2025 |
| KAHR | Series B | $46.5M | Jun 2021 |
Top Co-Investors
aMoon2 shared
Cancer Focus Fund1 shared
Pavilion Capital1 shared
Mirae Asset1 shared
Columbus Venture Partners1 shared
Pontifax1 shared
Last updated: 3 March 2026